Alberta Investment Management Corp (AIMCo)’s Corcept Therapeutics CORT Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.84M	Buy	+113,200	New	+$6.84M	0.06%	227
2023 Q2	–	Sell	-26,360	Closed	-$571K	–	1235
2023 Q1	$571K	Sell	26,360 -6,512	-20%	-$143K	0.01%	933
2022 Q4	$668K	Buy	32,872 +14,241	+76%	+$357K	0.01%	881
2022 Q3	$478K	Buy	+18,631	New	+$499K	﹤0.01%	1081
2021 Q3	–	Sell	-37,100	Closed	-$816K	–	971
2021 Q2	$816K	Hold	37,100	–	–	0.01%	810
2021 Q1	$883K	Sell	37,100 -18,600	-33%	-$497K	0.01%	693
2020 Q4	$1.46M	Sell	55,700 -116,800	-68%	-$2.46M	0.01%	587
2020 Q3	$3M	Sell	172,500 -12,700	-7%	-$202K	0.03%	448
2020 Q2	$3.12M	Buy	+185,200	New	+$2.6M	0.04%	427
2020 Q1	–	Sell	-193,500	Closed	-$2.34M	–	961
2019 Q4	$2.34M	Buy	193,500 +117,500	+155%	+$1.64M	0.02%	475
2019 Q3	$1.07M	Buy	+76,000	New	+$934K	0.01%	623
2017 Q4	–	Sell	-22,700	Closed	-$438K	–	742
2017 Q3	$438K	Hold	22,700	–	–	﹤0.01%	664
2017 Q2	$268K	Sell	22,700 -23,000	-50%	-$250K	﹤0.01%	695
2017 Q1	$501K	Buy	+45,700	New	+$401K	﹤0.01%	687

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s CORT Position: Q2 2026 in Review

Alberta Investment Management Corp (AIMCo) opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 113,200 shares worth $9.84M. The stake represents 0.06% of the portfolio and ranks #227 among its holdings. This is a return to the name: Alberta Investment Management Corp (AIMCo) previously reported a position in CORT as recently as Q1 2023.

Alberta Investment Management Corp (AIMCo) first reported a position in CORT in Q1 2017 and has held it in 14 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Alberta Investment Management Corp (AIMCo) held 113,200 shares of Corcept Therapeutics worth $9.84M as of Q2 2026.
Corcept Therapeutics was a new Alberta Investment Management Corp (AIMCo) position in Q2 2026.
Corcept Therapeutics made up 0.06% of Alberta Investment Management Corp (AIMCo)'s portfolio in Q2 2026, its #227 holding.
Alberta Investment Management Corp (AIMCo) first reported a position in Corcept Therapeutics in Q1 2017 and has held it in 14 quarters since.
422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2026, filed 6 Aug 2026.